EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Jay Duker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD announced at ASRS 2022...
Bostonâs hospital chiefs moonlight on corporate boards at rates far beyond the national level Hospital chiefs and trustees defend this as boosting public-private partnerships, but critics say these board positions - some paying millions of dollars - raise troubling issues of conflict of interest and hospital priorities. By Liz Kowalczyk, Spotlight fellow Sarah L. Ryley, Mark Arsenault and Spotlight editor Patricia Wen Globe Staff and Globe Staff,Updated April 3, 2021, 4:54 p.m. Email to a Friend Globe Staff/Photo Illustration by Globe Staff As chief of Boston Childrenâs Hospital, o...